New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
ESSA Pharma, Inc. (EPIX)
EPIX · NCM · Common · CUSIP 29668H104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EPIX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29668H104
Business: ESSA Pharma, Inc. is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.

Company Contact

CEO
David R. Parkinson
CFO
David Wood
Headquarters
Suite 720, 999 West Broadway, Vancouver, BC V5Z 1K5
Phone
778-331-0962
Investor Relations
David Wood · 778-331-0962 · dwood@essapharma.com
General Email
info@essapharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »